Astera Labs (NASDAQ:ALAB) CEO Sells $7,173,329.94 in Stock

Astera Labs, Inc. (NASDAQ:ALAB) CEO Jitendra Mohan sold 28,737 shares of Astera Labs stock in a transaction on Tuesday, May 19th. The stock was sold at an average price of $249.62, for a total value of $7,173,329.94. Following the sale, the chief executive officer directly owned 3,789,232 shares of the company’s stock, valued at approximately $945,868,091.84. This trade represents a 0.75% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jitendra Mohan also recently made the following trade(s):

• On Monday, May 18th, Jitendra Mohan sold 111,214 shares of Astera Labs stock. The stock was sold at an average price of $216.89, for a total value of $24,121,204.46.
• On Monday, May 18th, Jitendra Mohan sold 95,444 shares of Astera Labs stock. The stock was sold at an average price of $225.02, for a total value of $21,476,808.88.
• On Thursday, May 7th, Jitendra Mohan sold 139,951 shares of Astera Labs stock. The stock was sold at an average price of $200.16, for a total value of $28,012,592.16.
• On Monday, April 20th, Jitendra Mohan sold 10,188 shares of Astera Labs stock. The stock was sold at an average price of $175.45, for a total value of $1,787,484.60.
• On Friday, April 17th, Jitendra Mohan sold 325,693 shares of Astera Labs stock. The stock was sold at an average price of $172.14, for a total value of $56,064,793.02.
• On Wednesday, April 15th, Jitendra Mohan sold 2,967 shares of Astera Labs stock. The stock was sold at an average price of $174.60, for a total value of $518,038.20.
• On Friday, April 10th, Jitendra Mohan sold 123,750 shares of Astera Labs stock. The shares were sold at an average price of $149.68, for a total value of $18,522,900.00.
• On Tuesday, March 17th, Jitendra Mohan sold 157,500 shares of Astera Labs stock. The shares were sold at an average price of $131.58, for a total value of $20,723,850.00.

Astera Labs Stock Performance

NASDAQ:ALAB traded up $43.22 on Wednesday, reaching $287.48. The company’s stock had a trading volume of 10,253,769 shares, compared to its average volume of 5,914,570. Astera Labs, Inc. has a 1-year low of $84.78 and a 1-year high of $287.70. The firm has a market cap of $49.28 billion, a PE ratio of 194.24, a PEG ratio of 3.23 and a beta of 3.35. The business’s 50-day moving average price is $163.12 and its two-hundred day moving average price is $157.97.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. During the same period in the previous year, the firm earned $0.33 earnings per share. The company’s revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, sell-side analysts expect that Astera Labs, Inc. will post 1.84 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the company. Royal Bank Of Canada boosted their target price on Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a research note on Wednesday, May 6th. Evercore reissued an “outperform” rating and issued a $297.00 target price on shares of Astera Labs in a research note on Tuesday. Needham & Company LLC boosted their target price on Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a research note on Wednesday, May 6th. JPMorgan Chase & Co. boosted their target price on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. Finally, TD Cowen boosted their price target on Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a report on Wednesday, May 6th. Fifteen investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $233.75.

Institutional Trading of Astera Labs

A number of institutional investors have recently modified their holdings of ALAB. Royal Bank of Canada lifted its holdings in shares of Astera Labs by 167.3% in the first quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock valued at $9,097,000 after purchasing an additional 95,409 shares in the last quarter. AQR Capital Management LLC lifted its holdings in shares of Astera Labs by 213.4% in the first quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock valued at $680,000 after purchasing an additional 7,756 shares in the last quarter. Empowered Funds LLC lifted its holdings in shares of Astera Labs by 917.3% in the first quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock valued at $277,000 after purchasing an additional 4,183 shares in the last quarter. First Trust Advisors LP lifted its holdings in shares of Astera Labs by 102.0% in the second quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock valued at $10,196,000 after purchasing an additional 56,952 shares in the last quarter. Finally, Brown Advisory Inc. lifted its holdings in shares of Astera Labs by 54.9% in the second quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock valued at $505,000 after purchasing an additional 1,977 shares in the last quarter. 60.47% of the stock is currently owned by institutional investors.

Key Stories Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Wall Street optimism and a fresh analyst “buy” call helped fuel the rally, with investors viewing Astera Labs as a strong AI play. Astera Labs (ALAB) Soars 13% on Analyst ‘Buy’ Reco
• Positive Sentiment: Management commentary about a new switch timeline and potential revenue opportunities in optical networking boosted sentiment around future growth catalysts. Here’s why Astera Labs’ stock just staged a big gain
• Positive Sentiment: Traders also pointed to a “Power Inflow” alert and unusually heavy call-option buying, suggesting aggressive bullish positioning and momentum chasing in the stock. Astera Labs Shares Rise Over 6 Percent After Key Trading Signal
• Positive Sentiment: The stock is also being bid up after a Barron’s report said it is on pace for a record high, reinforcing the market’s view that Astera Labs is emerging as a notable AI infrastructure winner. Astera Labs Stock on Pace for Record High. Why It’s Up Double Digits for a Second Day.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.